See more : Q Technology (Group) Company Limited (1478.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Rhinomed Limited (RNO.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rhinomed Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- BFL Asset Finvest Limited (BFLAFL.BO) Income Statement Analysis – Financial Results
- Yale Transaction Finders, Inc. (YTFD) Income Statement Analysis – Financial Results
- Anaam International Holding Group Company (4061.SR) Income Statement Analysis – Financial Results
- Wynn Macau, Limited (WYNMF) Income Statement Analysis – Financial Results
- Bafang Yunji International Company Limited (2753.TW) Income Statement Analysis – Financial Results
Rhinomed Limited (RNO.AX)
About Rhinomed Limited
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is headquartered in Cremorne, Australia.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.47M | 9.10M | 3.89M | 3.57M | 3.35M | 2.25M | 1.83M | 1.01M | 432.46K | 210.85K | 291.99K | 0.00 | 33.72K | 0.00 | 0.00 | 3.03K |
Cost of Revenue | 7.66M | 7.48M | 6.98M | 6.36M | 1.09M | 607.45K | 388.31K | 314.00K | 258.91K | 56.75K | 0.00 | 0.00 | 0.00 | 0.00 | 24.58K | 3.41K |
Gross Profit | -190.44K | 1.62M | -3.09M | -2.79M | 2.26M | 1.64M | 1.44M | 698.44K | 173.55K | 154.10K | 291.99K | 0.00 | 33.72K | 0.00 | -24.58K | -375.00 |
Gross Profit Ratio | -2.55% | 17.80% | -79.24% | -78.34% | 67.41% | 72.96% | 78.76% | 68.99% | 40.13% | 73.08% | 100.00% | 0.00% | 100.00% | 0.00% | 0.00% | -12.38% |
Research & Development | 1.16M | 1.72M | 731.93K | 179.84K | 404.17K | 172.98K | 95.23K | 275.60K | 947.84K | 441.37K | 119.51K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.31M | 1.21M | 1.66M | 1.71M | 1.60M | 1.46M | 1.40M | 1.41M | 1.58M | 931.78K | 2.44M | 2.07M | 101.97K | 230.24K | 446.10K | 464.55K |
Selling & Marketing | 5.62M | 4.76M | 3.36M | 2.59M | 2.22M | 1.75M | 1.51M | 2.37M | 1.24M | 1.06M | 208.17K | 2.70M | 661.35K | 75.00 | 62.81K | 193.96K |
SG&A | 6.92M | 5.97M | 5.02M | 4.30M | 6.75M | 4.71M | 5.11M | 5.64M | 3.99M | 931.78K | 2.65M | 2.07M | 101.97K | 230.32K | 508.92K | 658.51K |
Other Expenses | -1.71M | 1.29M | 750.17K | 805.86K | 67.07K | 77.13K | 0.00 | -1.62K | -44.42K | 274.04K | -770.05K | 5.48M | -754.53K | -146.35K | -281.67K | -418.64K |
Operating Expenses | 9.80M | 7.69M | 5.75M | 4.48M | 8.21M | 5.73M | 6.19M | 7.16M | 6.12M | 4.25M | 4.57M | 6.17M | 1.33M | 679.63K | 900.58K | 1.43M |
Cost & Expenses | 17.46M | 15.17M | 12.73M | 10.84M | 9.30M | 6.34M | 6.57M | 7.47M | 6.37M | 4.44M | 4.57M | 6.17M | 1.33M | 679.63K | 925.13K | 1.43M |
Interest Income | 2.52K | 2.21K | 29.47K | 13.89K | 17.67K | 13.06K | 25.09K | 23.61K | 54.85K | 31.17K | 8.51K | 39.51K | 58.92K | 19.84K | 47.80K | 114.32K |
Interest Expense | 312.79K | 44.25K | 40.84K | 44.39K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 44.00 | 212.48K | 166.58K | 6.90K | 0.00 | 3.70K | 3.39K |
Depreciation & Amortization | 891.99K | 699.46K | 591.57K | 595.98K | 395.52K | 372.10K | 470.23K | 485.98K | 409.80K | 240.65K | 7.43K | 15.17K | 2.28K | 3.17K | 5.16K | 1.54K |
EBITDA | -9.10M | -5.37M | -8.25M | -7.44M | -4.93M | -3.31M | -3.83M | -5.18M | -5.46M | -4.01M | -4.30M | -639.65K | -1.32M | -477.83K | -872.20K | -1.31M |
EBITDA Ratio | -121.73% | -58.97% | -211.71% | -187.26% | -166.46% | -167.00% | -235.59% | -593.61% | -1,261.88% | -1,683.29% | -1,822.04% | 0.00% | -3,926.38% | 0.00% | 0.00% | -43,334.98% |
Operating Income | -9.99M | -6.07M | -8.84M | -7.27M | -5.95M | -4.09M | -4.75M | -6.50M | -5.87M | -4.23M | -4.57M | -6.17M | -1.18M | -679.63K | -925.13K | -1.43M |
Operating Income Ratio | -133.67% | -66.65% | -226.90% | -203.98% | -177.34% | -182.20% | -259.64% | -641.61% | -1,356.64% | -2,005.25% | -1,563.78% | 0.00% | -3,501.76% | 0.00% | 0.00% | -47,158.84% |
Total Other Income/Expenses | -1.50M | 745.39K | 212.62K | -30.74K | 17.67K | 13.06K | 25.09K | 59.88K | -20.42K | 305.17K | -11.07M | 5.35M | -86.54K | -178.79K | 44.08K | 110.93K |
Income Before Tax | -11.45M | -5.78M | -9.06M | -7.79M | -5.93M | -4.08M | -4.72M | -6.44M | -5.89M | -3.92M | -15.63M | -821.40K | -1.27M | -858.41K | -881.05K | -1.32M |
Income Before Tax Ratio | -153.22% | -63.50% | -232.68% | -218.42% | -176.81% | -181.62% | -258.26% | -635.70% | -1,361.36% | -1,860.51% | -5,354.17% | 0.00% | -3,758.40% | 0.00% | 0.00% | -43,497.82% |
Income Tax Expense | -540.89K | -500.42K | -423.86K | -521.07K | 12.05K | 75.42K | 279.94K | 437.46K | 570.34K | -388.39K | -666.54K | -59.28K | -941.35K | 178.79K | -29.00 | -415.25K |
Net Income | -10.91M | -5.28M | -8.64M | -7.27M | -5.94M | -4.00M | -4.44M | -6.00M | -5.32M | -3.53M | -19.56M | -1.30M | -1.14M | -858.41K | -881.03K | -1.32M |
Net Income Ratio | -145.98% | -58.00% | -221.80% | -203.80% | -177.17% | -178.26% | -242.95% | -592.49% | -1,229.48% | -1,676.31% | -6,698.78% | 0.00% | -3,379.10% | 0.00% | 0.00% | -43,497.82% |
EPS | -0.04 | -0.02 | -0.03 | -0.04 | -0.04 | -0.04 | -0.07 | -0.09 | -0.11 | -0.10 | -0.81 | -0.10 | -0.19 | -0.38 | -0.41 | -0.64 |
EPS Diluted | -0.04 | -0.02 | -0.03 | -0.04 | -0.04 | -0.04 | -0.07 | -0.09 | -0.11 | -0.10 | -0.81 | -0.10 | -0.19 | -0.38 | -0.41 | -0.64 |
Weighted Avg Shares Out | 285.56M | 261.44M | 255.53M | 164.97M | 133.08M | 106.93M | 67.19M | 63.61M | 47.48M | 34.88M | 23.86M | 13.35M | 6.06M | 2.23M | 2.17M | 2.07M |
Weighted Avg Shares Out (Dil) | 285.72M | 261.66M | 255.53M | 164.97M | 133.08M | 106.93M | 67.22M | 63.64M | 47.48M | 35.11M | 24.02M | 13.35M | 6.06M | 2.23M | 2.17M | 2.07M |
Source: https://incomestatements.info
Category: Stock Reports